Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Through Treatment With Intravenous Autologous Cerebrospinal Fluid - a Pilot Trial.

NCT04490161 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT04490161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04490161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Through Treatment With Intravenous Autologous Cerebrospinal Fluid - a Pilot Trial.
Lead sponsor
Medical University Innsbruck
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2020
Completion date
February 1, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, subarachnoid hemorrhage, subarachnoid hemorrhage, aneurysmal, vasospasm, cerebral